Articles > Business magazines > Trade magazines > Dental Lab Products articles > April 2009

Article: Spread the word

Article from:
Dental Lab Products
Article date:
April 1, 2009
Author:
Copyright

From a new cement specifically formulated for veneers to a most- welcome local anaesthetic reversal agent and a real-time mandibular recording device, here are three products featured in the February issue of Dental Products Report that your clients may have missed.

Denali Corp. introduced AURAVeneer self-adhesive VLC cement for optimal cementation of all-ceramic or composite restorations. Ihe no run, light-cure formulation has a film thickness of less than 12 microns ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Novalar Pharmaceuticals Inc.(HEALTH CARE AND ...
San Diego Business Journal;  January 21, 2008 ;     530 words ...Novalar Pharmaceuticals Inc. has announced two additions to its management team. Robert Stefanovich has been appointed chief financial officer, and Jeffrey Lord has been named vice president of sales.

Article: Reverse numbing drug to launch.(BIOTECH)(Novalar ...
San Diego Business Journal;  May 19, 2008 ;     700+ words ...Reverse Numbing Drug To Launch: A drug developed by privately-held Novalar Pharmaceuticals Inc. passed FDA muster May 12 and will launch later this year. The drug, OraVerse, works to reverse the numbing effects of ...

Article: Novalar Pharmaceuticals Inc.(HEALTH CARE AND ...
San Diego Business Journal;  February 4, 2008 ;     531 words ...Novalar Pharmaceuticals Inc. has added Robert Stefanovich and Jeffery Lord to the company. Stefanovich has been appointed chief financial officer and Lord has been appointed vice president of sales.

Article: Novalar Pharmaceuticals.(MANUFACTURERS)
Medical Marketing & Media;  February 1, 2008 ;     328 words ...Novalar Pharmaceuticals, a dental specialty pharmaceutical company has appointed Robert Stefanovich CFO and Jeffrey Lord VP of sales.

Article: Numb no more.(BIOTECH)(Novalar Pharmaceuticals ...
San Diego Business Journal;  April 16, 2007 ;     635 words ...Numb No More: Novalar Pharmaceuticals Inc. submitted a new drug application recently to the Food and Drug Administration for its local anesthetic reversal agent. The ...

Article: NEA Completes Investment in Novalar ...
Business Wire;  November 1, 2007 ;     700+ words ... ... Inc. (NEA) today announced that the firm has led a Series D investment in San Diego, California-based Novalar Pharmaceuticals, Inc. The funds will be used to support Novalar's anticipated U.S. launch of NV-101, a first-in ...

Article: Novalar sinks its teeth in $600m dental treatment ...
San Diego Business Journal;  March 9, 2009 ;     700+ words ...Following FDA approval in May, Carmel Valley-based Novalar Pharmaceuticals launched its first product Feb. 27 at a national dental convention in Chicago. OraVerse, an injection made with an anti-hypertensive ...

Article: Patent No. 7,569,230 Issued on Aug. 4, Assigned to Novalar ...
US Fed News Service, Including US State News;  August 10, 2009 ;     376 words ... ... The inventors were issued U.S. Patent No. 7,569,230 on Aug. 4. The patent has been assigned to Novalar Pharmaceuticals Inc., San Diego. According to the description released by the U.S. Patent & Trademark Office ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives